Correlation Between Merck and Accretion Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Accretion Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Accretion Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Accretion Acquisition Corp, you can compare the effects of market volatilities on Merck and Accretion Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Accretion Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Accretion Acquisition.

Diversification Opportunities for Merck and Accretion Acquisition

-0.93
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Merck and Accretion is -0.93. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Accretion Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Accretion Acquisition and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Accretion Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Accretion Acquisition has no effect on the direction of Merck i.e., Merck and Accretion Acquisition go up and down completely randomly.

Pair Corralation between Merck and Accretion Acquisition

Considering the 90-day investment horizon Merck is expected to generate 3.33 times less return on investment than Accretion Acquisition. In addition to that, Merck is 9.32 times more volatile than Accretion Acquisition Corp. It trades about 0.01 of its total potential returns per unit of risk. Accretion Acquisition Corp is currently generating about 0.19 per unit of volatility. If you would invest  1,001  in Accretion Acquisition Corp on August 30, 2024 and sell it today you would earn a total of  41.00  from holding Accretion Acquisition Corp or generate 4.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy31.31%
ValuesDaily Returns

Merck Company  vs.  Accretion Acquisition Corp

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Accretion Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Accretion Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical and fundamental indicators, Accretion Acquisition is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Merck and Accretion Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Accretion Acquisition

The main advantage of trading using opposite Merck and Accretion Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Accretion Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accretion Acquisition will offset losses from the drop in Accretion Acquisition's long position.
The idea behind Merck Company and Accretion Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets